Results 131 to 140 of about 8,213 (208)

Antiviral and immunoregulatory effects of curcumin on coxsackievirus B3-infected hepatitis. [PDF]

Virus Res, 2023
Lin YJ, Wang LC, Tsai HP, Chi CY, Chang CP, Chen SH, Wang SM.   +6 more
europepmc   +1 more source

Does Coxsackievirus B3 Require Autophagosome Formation for Replication? Evidence for an Autophagosome-Independent Mechanism: Insights into Its Limited Potential as a Therapeutic Target. [PDF]

Pharmaceuticals (Basel)
Ga YJ, Yeh JY.
europepmc   +1 more source

Cytoplasm Hydrogelation-Mediated Cardiomyocyte Sponge Alleviated Coxsackievirus B3 Infection. [PDF]

Nano Lett, 2023
Wang J, Liu T, Gu S, Yang HH, Xie W, Gao C, Gu D.   +6 more
europepmc   +1 more source

Decoding IFN-mediated immunity and cell dynamics in viral encephalitis: Insights from coxsackievirus B3 infection. [PDF]

iScience
Stach LM, Huis In 't Veld LGM, Schaub T, Jendrach M, Ornaghi M, Schwabenland M, Beling A, Pinkert S.   +7 more
europepmc   +1 more source

A viral-specific CD4⁺ T cell response protects female mice from Coxsackievirus B3 infection. [PDF]

Front Immunol, 2023
Pattnaik A, Dhalech AH, Condotta SA, Corn C, Richer MJ, Snell LM, Robinson CM.   +6 more
europepmc   +1 more source

Unraveling the molecular basis of membrane-associated release of coxsackievirus B3. [PDF]

Sci Rep
Arce R, Soñora M, Andreu-Moreno I, Moreno P, Moratorio G, Sanjuán R.   +5 more
europepmc   +1 more source

Transcriptome of brain-like endothelial cells following coxsackievirus B3 infection. [PDF]

Microbiol Resour Announc
Hathcock SF, Keyzer TE, Vollmuth N, Lam DW, Sin J, Kim BJ.   +5 more
europepmc   +1 more source

Sex differences in left-ventricular strain in a murine model of coxsackievirus B3 myocarditis. [PDF]

iScience, 2023
Di Florio DN, Macomb LP, Giresi PG, Beetler DJ, Bonvie-Hill NE, Shapiro KA, Naser AN, Khatib S, Whelan ER, Weigel GJ, Edenfield BH, Balamurugan V, Burris SK, Rich LJ, Bruno KA, Cooper LT, McLeod CJ, Yamani MH, Fairweather D.   +18 more
europepmc   +1 more source

Retraction Note: Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells. [PDF]

Virol J
Zhu H, Lou C, Liu P.
europepmc   +1 more source

Innovative use of gram-positive enhancer matrix particles and affinity peptides in a vaccine against Coxsackievirus B3. [PDF]

Virulence
Qian S, Li R, Chen G, Ma Y, Zhang X, Tang Z, Song Y, Xu Z, Zhang Z, He Y, Zhang X, Lu S, Yang Z, Song X, Yu W, Yu L.   +15 more
europepmc   +1 more source